Australasian Assoc of Nuclear Medicine Specialists (@ausnucmed) 's Twitter Profile
Australasian Assoc of Nuclear Medicine Specialists

@ausnucmed

AANMS is a representative body of medical practitioners working to promote and advance the practice of nuclear medicine for both diagnosis and therapy.

ID: 1250239026633699328

calendar_today15-04-2020 01:47:00

611 Tweet

1,1K Followers

504 Following

Boris Hadaschik (@profhadaschik) 's Twitter Profile Photo

I am very happy to share this updated collaborative effort! PSMA-PET–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study sciencedirect.com/science/articl…

ANSTO (@ansto) 's Twitter Profile Photo

Excited that Dr Karina Meredith, Director of the Environment Research and Technology Group, will be speaking this evening at the celebrated #ScienceMeetsParliament dinner joining other ANSTO representatives & esteemed guests

Excited that Dr Karina Meredith, Director of the Environment Research and Technology Group, will be speaking this evening at the celebrated #ScienceMeetsParliament dinner joining other ANSTO representatives & esteemed guests
Theranostics AANMS (@theranosticsaus) 's Twitter Profile Photo

Make sure this session is in your diary for next Monday. Another informative and interactive session on Theranostics - not to be missed.

Make sure this session is in your diary for next Monday.  Another informative and interactive session on Theranostics - not to be missed.
Australasian Assoc of Nuclear Medicine Specialists (@ausnucmed) 's Twitter Profile Photo

Great start on day one to our 2024 Theranostics Course. Stellar line up of international and nations expert speakers; over 250 delegates; interactive/live MDT sessions throughout the day. Dont miss day two. theranostics-course.aanms.org.au

Great start on day one to our 2024 Theranostics Course.
Stellar line up of international and nations expert speakers; over 250 delegates; interactive/live MDT sessions throughout the day.  Dont miss day two.
theranostics-course.aanms.org.au
Prof Geoff Currie AM (@drgeoffcurrie) 's Twitter Profile Photo

Australasian Assoc of Nuclear Medicine Specialists If you are in or near Sydney, why not hear from some amazing national and international speakers. The Saturday program can be a stand alone program for physicians. Register now.

<a href="/AusNucMed/">Australasian Assoc of Nuclear Medicine Specialists</a> If you are in or near Sydney, why not hear from some amazing national and international speakers. The Saturday program can be a stand alone program for physicians. Register now.
ANZSNM (@anzsnm1969) 's Twitter Profile Photo

We are pleased to announce the Launch of the Lancet Oncology Commission Report on Radiotherapy and Theranostics! Access the full paper authors.elsevier.com/c/1js3i5EIIgPe… #ANZSNM #NuclearMedicine #Theranostics

We are pleased to announce the Launch of the Lancet Oncology Commission Report on Radiotherapy and Theranostics!

Access the full paper authors.elsevier.com/c/1js3i5EIIgPe…

#ANZSNM #NuclearMedicine #Theranostics
Isotopia Molecular Imaging (@isotopia_global) 's Twitter Profile Photo

Nuclear medicine is transforming healthcare, from cancer treatment to Alzheimer’s breakthroughs. We celebrate the physicians, technologists & scientists behind these innovations. Proud to be part of this field at Isotopia, dedicated to advancing its life-saving potential.

Nuclear medicine is transforming healthcare, from cancer treatment to Alzheimer’s breakthroughs.
We celebrate the physicians, technologists &amp; scientists behind these innovations. 
Proud to be part of this field at Isotopia, dedicated to advancing its life-saving potential.
JNM (@journalofnucmed) 's Twitter Profile Photo

A triple-tracer imaging strategy can be exploited to detect intrapatient intermetastatic heterogeneity, helping to guide biopsy and personalize management of advanced #ProstateCancer. ow.ly/8UmV50Txx8o #NuclearMedicine #PETscan

A triple-tracer imaging strategy can be exploited to detect intrapatient intermetastatic heterogeneity, helping to guide biopsy and personalize management of advanced #ProstateCancer. ow.ly/8UmV50Txx8o 

#NuclearMedicine #PETscan
NeuroEndocrine Cancer Australia (@necanceraus) 's Twitter Profile Photo

16 Australians are diagnosed with neuroendocrine cancer every single day. Mark Butler MP and Anthony Albanese, we ask respectfully that your Government respond to the recent #SenateInquiry recommendations. #NeuroendocrineCancer patients deserve equitable support and care.

JNM (@journalofnucmed) 's Twitter Profile Photo

Efficacy and toxicity of ¹⁷⁷Lu-PSMA-617 for mCRPC: Results from the U.S. expanded-access program and comparisons with phase 3 VISION data. ow.ly/Kc0T50TxxgR #NuclearMedicine #ProstateCancer @VMurthymed Andrei Gafita Jeremie Calais Oliver Sartor Thomas Hope

Efficacy and toxicity of ¹⁷⁷Lu-PSMA-617 for mCRPC: Results from the U.S. expanded-access program and comparisons with phase 3 VISION data. ow.ly/Kc0T50TxxgR 

#NuclearMedicine #ProstateCancer @VMurthymed <a href="/DrAGafita/">Andrei Gafita</a> <a href="/CalaisJeremie/">Jeremie Calais</a> <a href="/sartor_oliver/">Oliver Sartor</a> <a href="/thomashopemd/">Thomas Hope</a>
SNMMI (@snm_mi) 's Twitter Profile Photo

Featured in this month's JNM: A novel PET technique can visualize spinal cord injuries by detecting intact nerve connections in the injured spinal cord. Using this technique gives doctors critical information about which patients may be able to regain mobility.

Featured in this month's <a href="/JournalofNucMed/">JNM</a>: A novel PET technique can visualize spinal cord injuries by detecting intact nerve connections in the injured spinal cord. Using this technique gives doctors critical information about which patients may be able to regain mobility.
Michael Hofman (@drmhofman) 's Twitter Profile Photo

Twenty cycles (that's right 20) of Lutetium-177 PSMA-617 for metastatic castration-resistant cancer!! Check our case report just published in JNM jnm.snmjournals.org/content/early/… Current randomized controlled data demonstrate the safety and efficacy of 6 cycles of

Michael Hofman (@drmhofman) 's Twitter Profile Photo

... how common is PSMA-negative significant prostate cancer? In the proPSMA study it was 3.3% Hot of the press in JNM: jnm.snmjournals.org/content/early/… Wonderful work from David Chen and team ProsTIC including James Buteau Declan Murphy

... how common is PSMA-negative significant prostate 
cancer? In the proPSMA study it was 3.3%

Hot of the press in <a href="/JournalofNucMed/">JNM</a>: jnm.snmjournals.org/content/early/…

Wonderful work from <a href="/davcmed/">David Chen</a> and team <a href="/pros_tic/">ProsTIC</a> including <a href="/ButeauJames/">James Buteau</a> <a href="/declangmurphy/">Declan Murphy</a>